These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27267120)

  • 21. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.
    Kim DW; Walker RL; Meltzer PS; Cheng SY
    Carcinogenesis; 2013 Oct; 34(10):2389-400. PubMed ID: 23698635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
    Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY
    Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer.
    Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY
    Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
    Zhou Q; Chen J; Feng J; Xu Y; Zheng W; Wang J
    Mol Cell Biochem; 2017 Nov; 435(1-2):87-95. PubMed ID: 28551845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
    Vo TT; Fruman DA
    Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
    Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
    PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
    Kato Y; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.
    Wang Y; Hou P; Yu H; Wang W; Ji M; Zhao S; Yan S; Sun X; Liu D; Shi B; Zhu G; Condouris S; Xing M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2387-90. PubMed ID: 17426084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.
    Antico Arciuch VG; Russo MA; Dima M; Kang KS; Dasrath F; Liao XH; Refetoff S; Montagna C; Di Cristofano A
    Oncotarget; 2011 Dec; 2(12):1109-26. PubMed ID: 22190384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
    Miao X; Zhao Y
    Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional telomere dynamics in follicular thyroid cancer.
    Wark L; Danescu A; Natarajan S; Zhu X; Cheng SY; Hombach-Klonisch S; Mai S; Klonisch T
    Thyroid; 2014 Feb; 24(2):296-304. PubMed ID: 23819464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
    Ying H; Willingham MC; Cheng SY
    Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
    Guigon CJ; Fozzatti L; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2010 Jul; 31(7):1284-91. PubMed ID: 20299527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.
    Huk DJ; Ashtekar A; Magner A; La Perle K; Kirschner LS
    Thyroid; 2018 Sep; 28(9):1153-1161. PubMed ID: 29882482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
    Yu W; He X; Ni Y; Ngeow J; Eng C
    Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
    Kim CS; Ying H; Willingham MC; Cheng SY
    Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.
    Hou P; Bojdani E; Xing M
    J Clin Endocrinol Metab; 2010 Feb; 95(2):820-8. PubMed ID: 20008023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.